Invesco
FENC icon

Invesco’s Fennec Pharmaceuticals FENC Stock Holding History

Invesco’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.8K Sell
11,677
-2,651
-19% -$20.5K ﹤0.01% 3662
2025
Q4 		$110K Buy
14,328
+2,201
+18% +$18.1K ﹤0.01% 3624
2025
Q3 		$114K Buy
12,127
+767
+7% +$6.64K ﹤0.01% 3666
2025
Q2 		$94.3K Buy
+11,360
New +$77.7K ﹤0.01% 3659
2021
Q2 		– Sell
-12,818
Closed -$80K – 3983
2021
Q1 		$80K Buy
12,818
+2,685
+26% +$20.2K ﹤0.01% 3784
2020
Q4 		$75K Buy
+10,133
New +$77.2K ﹤0.01% 3684

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Invesco's FENC Position: Q1 2026 in Review

Invesco reduced its Fennec Pharmaceuticals (FENC) stake by 19% in Q1 2026, selling an estimated $20.5K and leaving 11,677 shares worth $71.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3662.

Invesco first reported a position in FENC in Q4 2020 and has held it in 6 quarters since. The position peaked at $114K in Q3 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Invesco held 11,677 shares of Fennec Pharmaceuticals worth $71.8K as of Q1 2026.
  • Invesco sold 2,651 Fennec Pharmaceuticals shares in Q1 2026, an estimated $20.5K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3662 holding.
  • Invesco first reported a position in Fennec Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
  • Invesco's Fennec Pharmaceuticals position peaked at $114K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.